Genomic Biomarker Market
According to Intent Market Research, the Genomic Biomarker Market is expected to grow from USD 5.4 billion in 2024-e at a CAGR of 14.1% to touch USD 13.5 billion by 2030. The Genomic Biomarker Market is dominated by key players such as Thermo Fisher Scientific, Agilent Technologies, Roche Diagnostics, Illumina, Inc., Bio-Rad Laboratories, QIAGEN, Abbott Laboratories, PerkinElmer, GE Healthcare, Siemens Healthineers, Merck KGaA, Becton Dickinson and Company, Bio-Techne, Thermo Fisher Scientific, Pacific Biosciences of California.